Autor: |
Camargo-Coronel A; Rheumatology Department, Centro Médico Nacional Siglo XXI, Mexico City. adolfo_camargo@yahoo.com.mx., Quiñones-Moya H; Rheumatology Department, Centro Médico Nacional Siglo XXI, Mexico City. horacio_qmac@gmail.com., Hernández-Zavala MR; Rheumatology Department, Centro Médico Nacional Siglo XXI, Mexico City. mraulhdzzavala@gmail.com., Hernández-Vázquez JR; Rheumatology Department, Centro Médico Nacional Siglo XXI, Mexico City. ramiroson@comunidad.unam.mx., Vázquez-Zaragoza MÁ; Rheumatology Department, Centro Médico Nacional Siglo XXI, Mexico City. vazza78@hotmail.com. |
Jazyk: |
angličtina |
Zdroj: |
Reumatismo [Reumatismo] 2023 May 08; Vol. 75 (1). Date of Electronic Publication: 2023 May 08. |
DOI: |
10.4081/reumatismo.2023.1548 |
Abstrakt: |
The COVID-19 pandemic represents a global health problem, which has been mitigated by the opportune introduction of vaccination programs. Although we already know the benefit that vaccines provide, these are not exempt from adverse events which can be mild to deadly, such as idiopathic inflammatory myopathies, in which a temporal association has not been defined. It is for this reason that we carried out a systematic review of all reported cases of vaccination against COVID-19 and myositis. To identify previously reported cases of idiopathic inflammatory myopathies associated with vaccination against SARS-CoV-2 we registered this protocol on the website of PROSPERO with identification number CRD42022355551. Of the 63 publications identified in MEDLINE and 117 in Scopus, 21 studies were included, reporting 31 cases of patients with vaccination-associated myositis. Most of these cases were women (61.3%); mean age was 52.3 years (range 19-76 years) and mean time of symptom onset post-vaccination was 6.8 days. More than half of the cases were associated with Comirnaty, 11 cases (35.5%) were classified as dermatomyositis, and 9 (29%) as amyopathic dermatomyositis. In 6 (19.3%) patients another probable trigger was identified. Case reports of inflammatory myopathies associated with vaccination have heterogeneous presentations without any specific characteristics: as a consequence, it is not possible to ensure a temporal association between vaccination and the development of inflammatory myopathies. Large epidemiological studies are required to determine the existence of a causal association. |
Databáze: |
MEDLINE |
Externí odkaz: |
|